Sinsin Pharmaceutical Co. Ltd (002800.KQ) stock: key figures, P/E, revenue and dividend

Energy · Coal & Consumable Fuels · South Korea · ISIN KR7002800001

Price
3,915.00 KRW
Market cap
59.39 bn KRW
P/E (2025)
6.39
P/S (2025)
0.52
Dividend yield
2.04 %
Net margin
8.17 %
Return on equity (ROE)
12.42 %
Return on assets (ROA)
6.76 %

Sinsin Pharmaceutical Co. Ltd financials

Fiscal year20242025
Revenue106.39 bn KRW113.78 bn KRW
Gross profit36.22 bn KRW43.11 bn KRW
Operating income6.89 bn KRW10.79 bn KRW
EBIT7.10 bn KRW11.45 bn KRW
Net income4.89 bn KRW9.29 bn KRW
Diluted EPS – continuing operations322.24 KRW612.51 KRW

Full history since 2015, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Sinsin Pharmaceutical Co. Ltd

Sinsin Pharmaceutical Co., Ltd manufactures and sells pharmaceutical products in South Korea. It offers various medicinal products, such as plaster, aerosol, topical liquid, emollient, hygiene, and ointment products, as well as adhesive bandages, mosquito repellents, anti-perspirants, cooling sheets, bruise treatment creams, and other products. The company also develops transdermal drug delivery system, and bag on valve inhaler and aerosol solubilzation system. In addition, it exports its products to approximately 30 countries worldwide. The company was founded in 1959 and is headquartered in Sejong, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.